Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Companies
Recent news which mentions Companies
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
May 19, 2025
Tags
Breaking News: Business
LILLY DRN
Novo Nordisk A/S
From
CNBC.com News
Big Chinese companies like Alibaba show that AI-powered ads are giving shopping a boost
May 16, 2025
Tags
stocks
AI / Artificial Intelligence
Asia: Business
From
CNBC.com News
UnitedHealth Group shares plunge 18% on reported DOJ probe into possible Medicare fraud
May 15, 2025
Tags
Pharmaceuticals
Health care industry
Health & Science
From
CNBC.com News
UnitedHealth Group CEO Andrew Witty steps down, company suspends annual forecast
May 13, 2025
Tags
UnitedHealth Group Inc
Business News
Cigna Corp
From
CNBC.com News
Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know
May 12, 2025
Tags
Biotech and Pharmaceuticals
Health care industry
Bristol/Myers Squibb Co
From
CNBC.com News
Trump to sign order to cut some U.S. drug prices to match those abroad
May 12, 2025
Tags
Social issues
Companies
Biotechnology
From
CNBC.com News
Walgreens doubles down on prescription-filling robots to cut costs, free up pharmacists amid turnaround
May 11, 2025
Tags
Amazon/com Inc
Breaking News: Business
Biotechnology
From
CNBC.com News
Tech giant Seagate sees hard drive capacity tripling by 2030 on booming AI demand
May 07, 2025
Tags
Alphabet Inc
Hardware
Microsoft Corp
From
CNBC.com News
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
May 05, 2025
Tags
Biotech and Pharmaceuticals
Health care industry
Breaking News: Politics
From
CNBC.com News
Standard Chartered Q1 2025 profits beat expectations on strong wealth solutions growth
May 02, 2025
Tags
HSBC Holdings PLC
Breaking News: Markets
Asia Markets
From
CNBC.com News
Eli Lilly CEO says company can help 'respond' to national security concerns around essential drugs as tariffs loom
May 01, 2025
Tags
Business News
LILLY DRN
Breaking News: Business
From
CNBC.com News
Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal
May 01, 2025
Tags
Biotech and Pharmaceuticals
US: News
Business
From
CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
May 01, 2025
Tags
US: News
Business
Pharmaceuticals
From
CNBC.com News
CVS tops estimates, hikes guidance as insurance business shows some improvement
May 01, 2025
Tags
Business
US: News
Biotech and Pharmaceuticals
From
CNBC.com News
RFK Jr. is gutting minority health offices across HHS that are key to reducing health disparities
April 30, 2025
Tags
Health & Science
Pharmaceuticals
Business
From
CNBC.com News
Britain at risk of losing ground to rival fintech and crypto hubs, execs warn
April 30, 2025
Tags
Companies
Technology
Breaking News: Technology
From
CNBC.com News
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
April 29, 2025
Tags
Breaking News: Business
Business News
Companies
From
CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
April 29, 2025
Tags
Health & Science
Pharmaceuticals
Health care industry
From
CNBC.com News
Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall
April 29, 2025
Tags
Biotechnology
Companies
Breaking News: Business
From
CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
April 25, 2025
Tags
Biotech and Pharmaceuticals
Health care industry
Social issues
From
CNBC.com News
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
April 24, 2025
Tags
Biotechnology
Companies
Earnings
From
CNBC.com News
Merck lowers profit outlook, partly due to $200 million expected tariff hit
April 24, 2025
Tags
Companies
Biotechnology
Earnings
From
CNBC.com News
Adobe to launch mobile app for AI image generation tool as OpenAI steps up rivalry
April 24, 2025
Tags
Microsoft Corp
Mobile
Alphabet Inc
From
CNBC.com News
BP shares jump as activist investor Elliott discloses 5% stake build
April 23, 2025
Tickers
OIL
Tags
Markets
Energy
Business News
From
CNBC.com News
FDA to phase out dyes used in Flamin' Hot Cheetos, Skittles and other snacks
April 22, 2025
Tags
Restaurants
Health & Science
Pharmaceuticals
From
CNBC.com News
UnitedHealth's stock is plunging on higher medical costs. That may mean trouble for more insurers
April 17, 2025
Tags
Business News
Social issues
UnitedHealth Group Inc
From
CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
April 17, 2025
Tags
US: News
Business
Pharmaceuticals
From
CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
April 14, 2025
Tags
Business News
LILLY DRN
Biotech and Pharmaceuticals
From
CNBC.com News
30-year-old influencer made $4 million in sales by creating a luxury hair oil brand rooted in Indian traditions
April 14, 2025
Tickers
CEO
CEOS
Tags
CEOs
Entertainment
Skin care
From
CNBC.com News
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages
April 11, 2025
Tags
Companies
Biotechnology
Breaking News: Business
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.